Q3 2024 EPS Estimates for Alimera Sciences, Inc. (NASDAQ:ALIM) Decreased by Analyst

Alimera Sciences, Inc. (NASDAQ:ALIM – Free Report) – HC Wainwright cut their Q3 2024 earnings per share estimates for shares of Alimera Sciences in a report issued on Thursday, May 16th. HC Wainwright analyst Y. Chen now anticipates that the biopharmaceutical company will earn ($0.01) per share for the quarter, down from their prior forecast […]

Related Keywords

United States , ,Alimera Sciences ,Stonepine Capital Management ,Hedge Funds Weigh In On Alimera Sciences ,News Ratings For Alimera Sciences Daily ,Nasdaq ,Maxim Group ,Worth Venture Partners ,Alimera Sciences Stock Performance ,Vanguard Group Inc ,Capital Management ,Alimera Sciences Inc ,Free Report ,Alimera Science ,Get Free Report ,Venture Partners ,Lane Capital ,Vanguard Group ,Operating Cost ,Alimera Sciences Daily ,